Zylö Therapeutics
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $9.4M
Investors
- 8
About Zylö Therapeutics
Zylö Therapeutics Inc.Founded in 2017 and headquartered in Greenville, US, Zylö Therapeutics Inc. focuses on developing advanced delivery systems for therapeutic agents.Zylö Therapeutics specializes in enhancing topical delivery through its proprietary Z-pods technology, a unique encapsulation method designed for sustained delivery of therapeutic agents. The core product offerings focus on pharmaceutical and cosmetic applications, targeting improved efficacy and patient compliance in topical treatments. By utilizing the Z-pods system, Zylö Therapeutics aims to address common challenges in drug delivery, such as variable absorption rates and inconsistent therapeutic outcomes. The company primarily serves a diverse client base, including pharmaceutical manufacturers, skincare brands, and healthcare providers, focusing on markets in North America and Europe.Zylö Therapeutics generates revenue through partnerships and collaborations with pharmaceutical and cosmetic companies, leveraging its innovative Z-pods technology for their product offerings. The company engages in business transactions primarily through B2B agreements, where clients license the Z-pods technology or integrate it into their own formulations. This structure facilitates a consistent revenue stream as clients may pay upfront licensing fees or ongoing royalties based on product sales. The company’s flagship Z-pods technology is integral to their business model, allowing for scalable solutions tailored to the needs of various clients.23 million in June 2022, Zylö Therapeutics plans to enhance its internal research projects and accelerate the manufacturing process of its Z-pod® delivery particles. The company is focused on developing new product lines tailored for expanded market reach into both North America and Europe, with specific attention on consumer health and clinical applications. These initiatives are expected to drive growth and innovation within their product offerings.
Who invested in Zylö Therapeutics
8 investors across 3 rounds
See all investors in Zylö Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zylö Therapeutics
Who invested in Zylö Therapeutics?
Zylö Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zylö Therapeutics raised?
Zylö Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zylö Therapeutics last raise money?
Zylö Therapeutics's most recent round on record is a Series B, in Jun 2022.
What does Zylö Therapeutics do?
Zylö Therapeutics is a biotechnology company.
Where is Zylö Therapeutics headquartered?
Zylö Therapeutics is headquartered in Greenville, US.
Which VCs invest in companies like Zylö Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zylö Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Zylö Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.